NCT01246089 arm group 30fd6821a1e6f5d69ef9affb7ad1f7fb [clinicaltrials_resource:NCT01246089/arm-group/30fd6821a1e6f5d69ef9affb7ad1f7fb]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01246089 arm group 30fd6821a1e6f5d69ef9affb7ad1f7fb [clinicaltrials_resource:NCT01246089/arm-group/30fd6821a1e6f5d69ef9affb7ad1f7fb]
Bio2RDF identifier
NCT01246089/arm-group/30fd6821a1e6f5d69ef9affb7ad1f7fb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... fd6821a1e6f5d69ef9affb7ad1f7fb
description [clinicaltrials_vocabulary:description]
Myopic eyes with retinal neovascularization
identifier
clinicaltrials_resource:NCT01246089/arm-group/30fd6821a1e6f5d69ef9affb7ad1f7fb
title
NCT01246089 arm group 30fd6821a1e6f5d69ef9affb7ad1f7fb
@en
type
label
NCT01246089 arm group 30fd6821 ...... d6821a1e6f5d69ef9affb7ad1f7fb]
@en